— Know what they know.
Not Investment Advice

BIEL OTC

Bioelectronics Corporation
1W: +0.0% 1M: +0.0% 3M: +20.0% YTD: -25.0% 1Y: +100.0% 3Y: -25.0% 5Y: -84.2%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±50.0%
$-0 $0 $0 $0 $0
OTC · Healthcare · Medical - Specialties · Tech Score Neutral · Power 49 · $7.4M mcap · 7.53B float · 0.137% daily turnover · Short 25% of daily vol

Balance Sheet Trends

Total Assets
$43K -70.0% ▼
5Y CAGR: -34.0%
Total Liabilities
$17M +5.0% ▲
5Y CAGR: +3.2%
Shareholders Equity
-$17M -5.6% ▼
Cash & Investments
$8K +68.0% ▲
5Y CAGR: -29.8%
Total Debt
$16M +4.7% ▲
5Y CAGR: +3.9%
Net Debt
$16M +4.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$110K$925$45K$5K$8K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$110K$925$45K$5K$8K
Net Receivables$164K$58K$79K$99K$4K
Inventory$152K$25K$127K$41K$31K
Other Current Assets$0$0$0$0$0
Total Current Assets$425K$84K$250K$144K$43K
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$0$0$0$0$0
Total Assets$425K$84K$250K$144K$43K
— Liabilities —
Accounts Payable$735K$648K$737K$802K$1M
Short-Term Debt$6M$4M$2M$2M$2M
Deferred Revenue$0$95K$253K$208K$101K
Other Current Liabilities$2M$483K$926K$726K$792K
Total Current Liabilities$9M$6M$4M$4M$4M
Long-Term Debt$7M$9M$12M$13M$13M
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$7M$9M$12M$13M$13M
Total Liabilities$16M$15M$16M$17M$17M
— Equity —
Common Stock$24M$24M$23M$23M$23M
Retained Earnings-$38M-$38M-$39M-$40M-$41M
Accumulated OCI-$1M-$1M$23M$0$0
Total Stockholders Equity-$15M-$15M-$16M-$16M-$17M
Total Liabilities & Equity$425K$84K$250K$144K$43K
— Key Metrics —
Total Debt$13M$13M$14M$15M$16M
Net Debt$13M$13M$14M$15M$16M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms